Epi-Andro Rx

by IronMagLabs · capsule · 60 capsules

  • On the market (NIH)
  • DSLD label 47360
  • Serving 1 to 2 capsules; amounts per 1 capsule
  • 60 servings

Epi-Andro Rx by IronMagLabs lists 3 ingredients, 3 with an amount per serving of 1 capsule, such as 50 mg of 3b-hydroxy-androstane-3b-ol,17-one, 15 mg of 6,7-dihydroxybergmottin and 5 mg of piperine. Its current label entered the NIH Dietary Supplement Label Database on July 24, 2015.

What is in Epi-Andro Rx?

Each row as the label prints it, per serving of 1 capsule. The capsule beside an amount places it among every product in the NIH database that lists the same ingredient: the bar is the middle half of their amounts, the line in it the median, the whiskers the 10th and 90th percentiles; the green tick is the FDA Daily Value and the red dashed tick the adult upper limit (IOM).

Epi-Andro Rx: Supplement Facts rows against the market (DSLD label 47360, January 2026 release)
IngredientAmount% DVAmong products listing it
3b-Hydroxy-androstane-3b-ol,17-one50 mg
6,7-Dihydroxybergmottin15 mg
Piperine5 mgPiperine in EPI-ANDRO RX against 203 products5 mg per serving; the middle half of products list 4.75 mg to 10 mg, the median 5 mg.5 mg

40% of 203 products listing piperine give more (median 5 mg). Per day at the most servings: 10 mg.

Source: NIH ODS Dietary Supplement Label Database, label 47360 (entered July 24, 2015), version 9.4.0. See the label on DSLD. Amounts are what the maker printed; DSLD does not test products. Daily Values: the FDA's Daily Value page.

Is that a lot?

Every amount on this label with a position sits within the middle 80% of the products that list the same ingredient.

The NIH database records 2 servings a day from the label's directions; its % Daily Values are for adults and children 4 or more years of age. The directions as printed are further down this page.

The Tolerable Upper Intake Level is the most of a nutrient per day, from food, water and supplements together, that is likely to pose no risk for almost all adults (Institute of Medicine, 2011). It does not apply under medical supervision. This page compares labels; it is not medical advice.

Sources: amounts from the DSLD label; Daily Values from 21 CFR 101.9(c)(8)(iv); adult upper limits from the Institute of Medicine's DRI summary tables (2011). How positions are computed.

Which products have the closest formulas?

The products whose ingredient lists overlap most with Epi-Andro Rx's, rare ingredients counting for more.

Source: ingredient lists of every product's current label in DSLD (version 9.4.0); similarity weights each shared ingredient by how rare it is.

What does the label say about taking it?

Quoted from the label as DSLD transcribed it: the maker's words, including any claim about what the product does, which the FDA has not evaluated and PlainVitamins does not endorse.

Directions
Suggested use: As a dietary supplement take one (1) to two (2) capsules twice daily. Do not use EPI-ANDRO RX(TM) for longer than 8 weeks, and then take 8 weeks off. E-Control 2.0 RX, Post Cycle Therapy is highly recommended after completion of a cycle.
Warnings
Warning: Do not exceed the recommended dose.
Keep out of reach of children.
Consult your physician before using this dietary supplement. Do not use this product if you are at risk or being treated for high blood pressure, kidney, thyroid or psychiatric disease, difficulty in urinating, prostate enlargement, anxiety, depression, seizure disorder, or stroke.
Do not use if seal is damaged or missing.
Storage
Store in a cool place.

Source: label statements in DSLD label 47360.

What else is on the label?

Other ingredients: Rice Flour, Gelatine, Magnesium Stearate, Stearic Acid, Silica.

How many labels does Epi-Andro Rx have?

One label is on file, entered on July 24, 2015.

  1. Label 47360 (current) Entered July 24, 2015 · on the market · 60 capsules

Source: DSLD label entry and market events, version 9.4.0 (labels entered through September 25, 2025).

Who makes it?

The label names IronMagLabs (manufacturer). All IronMagLabs products.

Where next?